Correlation Between Lipella Pharmaceuticals and Mustang Bio

Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lipella Pharmaceuticals Common and Mustang Bio, you can compare the effects of market volatilities on Lipella Pharmaceuticals and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and Mustang Bio.

Diversification Opportunities for Lipella Pharmaceuticals and Mustang Bio

0.13

Correlation Coefficient

Lipella Pharmaceuticals  Mustang Bio

Average diversification

The 3 months correlation between Lipella and Mustang is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and Mustang Bio go up and down completely randomly.

Pair Corralation between Lipella Pharmaceuticals and Mustang Bio

Given the investment horizon of 90 days Lipella Pharmaceuticals Common is expected to generate 1.46 times more return on investment than Mustang Bio. However, Lipella Pharmaceuticals is 1.46 times more volatile than Mustang Bio. It trades about 0.03 of its potential returns per unit of risk. Mustang Bio is currently generating about -0.26 per unit of risk. If you would invest  310.00  in Lipella Pharmaceuticals Common on December 21, 2024 and sell it today you would lose (50.00) from holding Lipella Pharmaceuticals Common or give up 16.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lipella Pharmaceuticals Common  vs.  Mustang Bio

Lipella Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lipella Pharmaceuticals Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Lipella Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Mustang Bio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mustang Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Lipella Pharmaceuticals and Mustang Bio

The main advantage of trading using opposite Lipella Pharmaceuticals and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.

The idea behind Lipella Pharmaceuticals Common and Mustang Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.